Clinical Trial Update: Autologous CARTmeso/19 Against Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

Autologous CARTmeso/19 CAR-T therapy is being studied for pancreatic cancer in an early-phase trial sponsored by the First Affiliated Hospital of Wenzhou Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CARTmeso/19 (CAR-T therapy targeting mesothelin)

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Pancreatic Cancer | EARLY_Phase 1 | Status: UNKNOWN